Cognitive profile of chronic kidney disease and hemodialysis patients without dementia

Nephron - Clinical Practice

Volumn 116, Issue 3, 2010, Pages

  Post, James B ^a,b,d,e   Jegede, Adejoke B ^b   Morin, Kel ^b   Spungen, Ann M ^b,d   Langhoff, Erik ^a,d   Sano, Mary ^c,d  

^a Nephrology Division   (United States)

^b VA RR and D Center of Excellence for Medical Consequences of SCI   (United States)

^c VA RR and D   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cerebrovascular disease; Chronic kidney disease; Cognition; Hemodialysis; Mild cognitive impairment

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COGNITION; CONTROLLED STUDY; DEMENTIA; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COGNITION DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; EXECUTIVE FUNCTION; HUMANS; KIDNEY DISEASES; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; RENAL DIALYSIS; RISK FACTORS;

EID: 77954179641     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317206     Document Type: Article

References (40)

1. Sehgal AR, Grey SF, DeOreo PB, Whitehouse PJ: Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis 1997; 30: 41-49.
2. Murray AM, Tupper DE, Knopman DS, Gilbertson DT, Pederson SL, Li S, Smith GE, Hochhalter AK, Collins AJ, Kane RL: Cognitive impairment in hemodialysis patients is common. Neurology 2006; 67: 216-223.
3. Kurella Tamura M, Wadley V, Yaffe K, Mc- Clure LA, Howard G, Go R, Allman RM, Warnock DG, McClellan W: Kidney function and cognitive impairment in us adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis 2008; 52: 227-234.
4. Kurella M, Chertow GM, Luan J, Yaffe K: Cognitive impairment in chronic kidney disease. J Am Geriatr Soc 2004; 52: 1863-1869.
5. Martinez-Vea A, Salvado E, Bardaji A, Gutierrez C, Ramos A, Garcia C, Compte T, Peralta C, Broch M, Pastor R, Angelet P, Marcas L, Sauri A, Oliver JA: Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis 2006; 47: 241-250.
6. Fazekas G, Fazekas F, Schmidt R, Kapeller P, Offenbacher H, Krejs GJ: Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci 1995; 134: 83-88.
7. Ikram MA, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Breteler MM: Kidney function is related to cerebral small vessel disease. Stroke 2008; 39: 55-61.
8. Looi JC, Sachdev PS: Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 1999; 53: 670-678.
9. Roman GC, Royall DR: Executive control function: a rational basis for the diagnosis of vascular dementia. Alzheimer Dis Assoc Disord 1999; 13(suppl 3):S69-S80.
10. Petersen RC, Negash S: Mild cognitive impairment: an overview. CNS Spectr 2008; 13: 45-53.
11. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH: Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol 2003; 60: 1385-1389. (Pubitemid 37248799)
12. Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, Ivnik RJ, Tangalos EG, Petersen RC, Rocca WA: The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology 2008; 30: 58-69.
13. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
14. Folstein MF FS, McHugh PR: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
15. Delis D, Kramer J, Kaplan E, Ober B: California Verbal Learning Test, ed 2 (CVLT-II). San Antonio, Psychological Corp, 2000.
16. Benton AL, Hamsher KD: Multilingual Aphasia Examination, ed 3. Iowa City, AJA Associates, 1994.
17. Wechsler D: Wechsler Memory Scale, ed 3. Administration and Scoring Manual. San Antonio, Psychological Corp, 1997.
18. Smith A: Symbol Digit Modality Test (SDMT). Los Angeles, Western Psychological Services, 1991.
19. Reitan RWD: The Halstead-Reitan Neuropsychological Test Battery. Tuscon, Neuropsychology Press, 1988.
20. Golden JC: Stroop Color and Word Test. Chicago, Stoeling Corp, 1978.
21. Wetzel L, Boll T: Short Category Test, Booklet Format. Los Angeles, Western Psychological Services, 1986.
22. Lopez OL, Kuller LH, Fitzpatrick A, Ives D, Becker JT, Beauchamp N: Evaluation of dementia in the Cardiovascular Health Cognition Study. Neuroepidemiology 2003; 22: 1-12. (Pubitemid 36131968)
23. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194.
24. Pereira AA, Weiner DE, Scott T, Chandra P, Bluestein R, Griffith J, Sarnak MJ: Subcortical cognitive impairment in dialysis patients. Hemodial Int 2007; 11: 309-314.
25. Yaffe K, Petersen RC, Lindquist K, Kramer J, Miller B: Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord 2006; 22: 312-319.
26. Pugh KG, Lipsitz LA: The microvascular frontal-subcortical syndrome of aging. Neurobiol Aging 2002; 23: 421-431.
27. De Groot JC, de Leeuw FE, Oudkerk M, van Gijn J, Hofman A, Jolles J, Breteler MM: Cerebral white matter lesions and cognitive function: The Rotterdam Scan Study. Ann Neurol 2000; 47: 145-151.
28. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R: White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 1993; 50: 818-824.
29. Almkvist O, Wahlund LO, Andersson-Lundman G, Basun H, Backman L: White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992; 49: 626-632.
30. Boone KB, Miller BL, Lesser IM, Mehringer CM, Hill-Gutierrez E, Goldberg MA, Berman NG: Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect. Arch Neurol 1992; 49: 549-554.
31. Meyer JS, Quach M, Thornby J, Chowdhury M, Huang J: MRI identifies MCI subtypes: vascular versus neurodegenerative. J Neurol Sci 2005; 230: 121-129.
32. Weiner DE, Bartolomei K, Scott T, Price LL, Griffith JL, Rosenberg I, Levey AS, Folstein MF, Sarnak MJ: Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis 2009; 53: 438-447.
33. Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G: Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Kidney Int Suppl 2001; 78:S14-S18.
34. Hoth KF, Tate DF, Poppas A, Forman DE, Gunstad J, Moser DJ, Paul RH, Jefferson AL, Haley AP, Cohen RA: Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke 2007; 38: 308-312. (Pubitemid 46184300)
35. Arici M, Walls J: End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001; 59: 407-414.
36. Weiss MF, Erhard P, Kader-Attia FA, Wu YC, Deoreo PB, Araki A, Glomb MA, Monnier VM: Mechanisms for the formation of glycoxidation products in end-stage renal disease. Kidney Int 2000; 57: 2571-2585.
37. Raj DS, Choudhury D, Welbourne TC, Levi M: Advanced glycation end products: a nephrologist s perspective. Am J Kidney Dis 2000; 35: 365-380.
38. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-1538.
39. Prohovnik I, Post J, Uribarri J, Lee H, Sandu O, Langhoff E: Cerebrovascular effects of hemodialysis in chronic kidney disease. J Cereb Blood Flow Metab 2007; 27: 1861-1869.
40. Seliger SL, Longstreth WT Jr, Katz R, Manolio T, Fried LF, Shlipak M, Stehman-Breen CO, Newman A, Sarnak M, Gillen DL, Bleyer A, Siscovick DS: Cystatin C and subclinical brain infarction. J Am Soc Nephrol 2005; 16: 3721-3727.